WHO creates data base on use of child medicines

Jun 18, 2010

(AP) -- The World Health Organization on Friday issued its first-ever guidance on how to use more than 240 essential medicines for children under 13.

The data provide information on use, dosage and side effects of medicines as well as warnings about which children should not take them, the U.N. health agency said. The 528-page document also tells users about common drug interactions.

"To be effective, medicines must be carefully chosen and the dose adjusted to suit the age, weight and needs of children," said WHO's Dr Hans Hogerzeil.

"Without a global guide, many have had to prescribe medicines based on very limited evidence," he said in a statement.

Some countries have developed their own instructions for giving medicines to children, but there are no universal standards.

The WHO document only exists in English. But the agency recommends that governments use it as a model and translate it into their national language, spokeswoman Fadela Chaib said.

Around 8.8 million children under 5 die every year, many from diseases such as and that could be avoided with the correct use of medicines, according to WHO.

Explore further: FDA approves second vaccine against meningitis strain

More information: http://bit.ly/a9ttEd

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Children's medicine has additives

Mar 11, 2007

Britain's Food Commission finds most over-the-counter medication for young children contains additives that are banned from food for infants and toddlers.

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.